company background image
KAEF logo

Kimia Farma IDX:KAEF Stock Report

Last Price

Rp570.00

Market Cap

Rp3.2t

7D

-2.6%

1Y

-27.4%

Updated

23 Jun, 2024

Data

Company Financials

KAEF Stock Overview

Engages in the manufacturing and sale of pharmaceutical products in Indonesia.

KAEF fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

PT Kimia Farma Tbk Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kimia Farma
Historical stock prices
Current Share PriceRp570.00
52 Week HighRp1,935.00
52 Week LowRp550.00
Beta0.25
11 Month Change-29.63%
3 Month Change-38.38%
1 Year Change-27.39%
33 Year Change-79.64%
5 Year Change-83.04%
Change since IPO171.43%

Recent News & Updates

Recent updates

Shareholder Returns

KAEFID PharmaceuticalsID Market
7D-2.6%0.1%2.0%
1Y-27.4%-22.7%1.0%

Return vs Industry: KAEF underperformed the ID Pharmaceuticals industry which returned -22.7% over the past year.

Return vs Market: KAEF underperformed the ID Market which returned 1% over the past year.

Price Volatility

Is KAEF's price volatile compared to industry and market?
KAEF volatility
KAEF Average Weekly Movement8.5%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement5.8%
10% most volatile stocks in ID Market13.0%
10% least volatile stocks in ID Market2.7%

Stable Share Price: KAEF's share price has been volatile over the past 3 months.

Volatility Over Time: KAEF's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of ID stocks.

About the Company

FoundedEmployeesCEOWebsite
181711,461David Utamakimiafarma.co.id

PT Kimia Farma Tbk engages in the manufacturing and sale of pharmaceutical products in Indonesia. It also provides generic, ethical, license and narcotic medicines, over the counter medicines, raw materials, medicines, medical devices, and cosmetic products, as well as rapid test diagnostic tools. In addition, the company is involved manufacturing and marketing of pharmaceutical raw materials and active pharmaceutical ingredients; health foods and effervescent tablets; quinine salt and related derivatives; and castor oil and edible oil.

PT Kimia Farma Tbk Fundamentals Summary

How do Kimia Farma's earnings and revenue compare to its market cap?
KAEF fundamental statistics
Market capRp3.17t
Earnings (TTM)-Rp1.47t
Revenue (TTM)Rp9.97t

0.3x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KAEF income statement (TTM)
RevenueRp9.97t
Cost of RevenueRp7.60t
Gross ProfitRp2.37t
Other ExpensesRp3.84t
Earnings-Rp1.47t

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-263.38
Gross Margin23.77%
Net Profit Margin-14.71%
Debt/Equity Ratio119.8%

How did KAEF perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.